10-QPeriod: Q2 FY2015

AFLAC INC Quarterly Report for Q2 Ended Jun 30, 2015

Filed August 4, 2015For Securities:AFL

Summary

Aflac Inc.'s (AFL) Q2 2015 report shows a notable decline in net earnings and revenues compared to the prior year, largely attributed to the weakening Yen against the US Dollar, which impacted the translation of Aflac Japan's results. Net earnings for the quarter fell to $573 million ($1.32/share) from $810 million ($1.78/share) in Q2 2014. Similarly, six-month net earnings decreased to $1.24 billion ($2.83/share) from $1.54 billion ($3.38/share) in the comparable period of 2014. Despite the headline declines, the underlying insurance operations showed resilience. Aflac Japan's "third sector" products (cancer and medical) saw strong sales growth, driven by new product enhancements and expanded distribution through Japan Post. Aflac U.S. also reported modest growth in net premiums and new annualized premium sales, with a focus on improving its sales structure and claims processing. The company also managed its capital effectively by redeeming $850 million of high-coupon debt and issuing new, lower-interest notes, which is expected to provide interest savings. Investors should note the significant unrealized losses on investment securities, primarily due to changes in interest rates and credit spreads, which impacted other comprehensive income. While these unrealized losses are largely considered temporary, they reduced total shareholders' equity. The company continues to manage its investment portfolio with a focus on asset-liability matching and diversification.

Financial Statements
Beta
Revenue$5.29B
SG&A Expenses$550.00M
Operating Income$995.00M
Interest Expense$74.00M
Net Income$573.00M
EPS (Basic)$0.67
EPS (Diluted)$0.66
Shares Outstanding (Basic)863.34M
Shares Outstanding (Diluted)868.51M

Key Highlights

  • 1Net earnings declined significantly year-over-year, primarily due to the weakening Yen, which impacted the translation of Aflac Japan's results.
  • 2Aflac Japan's "third sector" insurance products (cancer and medical) experienced robust sales growth, reflecting a strategic focus on less interest-rate sensitive and more profitable offerings.
  • 3Aflac U.S. saw modest growth in net premiums and new annualized premium sales, supported by sales structure improvements and a focus on enhanced claims processing.
  • 4The company actively managed its debt by redeeming $850 million of high-coupon senior notes and issuing $1.0 billion in new notes with lower interest rates, economically converted to yen.
  • 5Total shareholders' equity was negatively impacted by substantial unrealized losses on investment securities, largely due to market interest rate and credit spread movements, though these are considered temporary.
  • 6The company's investment portfolio continues to be diversified across geographies and asset classes, with a focus on long-term asset-liability matching and credit quality.
  • 7Aflac's strong liquidity position was maintained, with significant cash flows from operations supporting investment activities and capital returns to shareholders through share repurchases and dividends.

Frequently Asked Questions

The primary reason for the decrease in net earnings is the significant weakening of the Japanese Yen against the US Dollar. This currency fluctuation negatively impacted the translation of Aflac Japan's financial results, which constitute a substantial portion of the company's overall performance.

Aflac Japan's performance is driven by sales of its "third sector" insurance products, such as cancer and medical insurance, which are less sensitive to interest rate fluctuations and more profitable. The company is actively expanding distribution channels, including a partnership with Japan Post, which is contributing to strong sales growth in these products. The segment's investment income is also a key driver, with a growing portion coming from dollar-denominated securities.

The company holds a significant investment portfolio. While investment income is a key contributor to earnings, the period saw substantial unrealized losses on investment securities due to market interest rate and credit spread changes. These unrealized losses reduced total shareholders' equity but are generally considered temporary. The company maintains a diversified investment strategy focused on asset-liability matching and credit quality.

Aflac recently redeemed $850 million of its higher-interest senior notes and issued $1.0 billion in new senior notes with lower interest rates. These new notes were economically converted into yen-denominated obligations through cross-currency swaps, reducing overall interest expenses and improving the company's capital structure. The company also continues to actively repurchase shares and pay dividends to shareholders.